Sanofi

A leading global pharmaceutical and medical device company, Sanofi leverages MIT LGO to improve their production of devices as well as vaccines. Sanofi’s state-of-the-art injection pen production facility near Frankfurt, Germany, is a prime site for the LGO-Sanofi relationship. In the facility, Sanofi is developing a smoother way to administer insulin to diabetes patients, and LGOs have made an impact by identifying innovative ways to eliminate device defects. LGO students also make important contributions to vaccine production as part of an overall digital transformation process within Sanofi.

Jeremy Schacherl (LGO ’16)

Location: Frankfurt, Germany
Research topic: Lean Optimization/Manufacturing
Jeremy used state-of-the-art nanoscale measurement techniques and tribological (friction) equipment to test the physical characteristics of silicone-coated glass. He then analyzed the data and determined the relative significance of primary factors influencing friction of a rubber versus coated glass system. His research was nominated for the Best Thesis Award in his graduating class.

Nathan McMullin (LGO ’15)

Location: Cambridge, MA and Frankfurt, Germany
Research topic: Product Design & Development
Nathan developed a product concept with an associated business case from recently acquired IP. He then recommended how to enhance the early stage development process. Billy Bellows (LGO ’14) had analyzed the acquired IP, generated an initial set of product ideas, and outlined a general process for taking new IP to product ideas. Nathan’s project continued Billy’s research through the rest of the opportunity identification process.